391 related articles for article (PubMed ID: 1845872)
1. Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man.
Rowe M; Young LS; Crocker J; Stokes H; Henderson S; Rickinson AB
J Exp Med; 1991 Jan; 173(1):147-58. PubMed ID: 1845872
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity among Epstein-Barr virus-seropositive donors in the generation of immunoblastic B-cell lymphomas in SCID mice receiving human peripheral blood leukocyte grafts.
Picchio GR; Kobayashi R; Kirven M; Baird SM; Kipps TJ; Mosier DE
Cancer Res; 1992 May; 52(9):2468-77. PubMed ID: 1314693
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Epstein-Barr virus-induced lymphoproliferation derived from human peripheral blood mononuclear cells transferred to severe combined immunodeficient mice.
Okano M; Taguchi Y; Nakamine H; Pirruccello SJ; Davis JR; Beisel KW; Kleveland KL; Sanger WG; Fordyce RR; Purtilo DT
Am J Pathol; 1990 Sep; 137(3):517-22. PubMed ID: 1975985
[TBL] [Abstract][Full Text] [Related]
4. EBV-induced human B cell lymphomas in hu-PBL-SCID mice.
Mosier DE; Picchio GR; Kirven MB; Garnier JL; Torbett BE; Baird SM; Kobayashi R; Kipps TJ
AIDS Res Hum Retroviruses; 1992 May; 8(5):735-40. PubMed ID: 1325170
[TBL] [Abstract][Full Text] [Related]
5. Low-dose interleukin 2 prevents the development of Epstein-Barr virus (EBV)-associated lymphoproliferative disease in scid/scid mice reconstituted i.p. with EBV-seropositive human peripheral blood lymphocytes.
Baiocchi RA; Caligiuri MA
Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5577-81. PubMed ID: 7911241
[TBL] [Abstract][Full Text] [Related]
6. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.
Lacerda JF; Ladanyi M; Louie DC; Fernandez JM; Papadopoulos EB; O'Reilly RJ
J Exp Med; 1996 Mar; 183(3):1215-28. PubMed ID: 8642263
[TBL] [Abstract][Full Text] [Related]
7. Human B-cell lymphoma in severe combined immunodeficient mice after active infection with Epstein-Barr virus.
Boyle TJ; Tamburini M; Berend KR; Kizilbash AM; Borowitz MJ; Lyerly HK
Surgery; 1992 Aug; 112(2):378-86. PubMed ID: 1322566
[TBL] [Abstract][Full Text] [Related]
8. Low expression of CD20 and CD23 in Epstein-Barr virus-induced B cell tumors in SCID/hu mice.
Garnier JL; Cooper NR; Cannon MJ
Am J Pathol; 1993 Feb; 142(2):353-8. PubMed ID: 7679547
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus induced lymphoproliferative tumors in severe combined immunodeficient mice are oligoclonal.
Pisa P; Cannon MJ; Pisa EK; Cooper NR; Fox RI
Blood; 1992 Jan; 79(1):173-9. PubMed ID: 1309425
[TBL] [Abstract][Full Text] [Related]
10. Plasmacytoid differentiation of Epstein-Barr virus-transformed B cells in vivo is associated with reduced expression of viral latent genes.
Rochford R; Hobbs MV; Garnier JL; Cooper NR; Cannon MJ
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):352-6. PubMed ID: 8380497
[TBL] [Abstract][Full Text] [Related]
11. SCID mouse model of Epstein-Barr virus-induced lymphomagenesis of immunodeficient humans.
Purtilo DT; Falk K; Pirruccello SJ; Nakamine H; Kleveland K; Davis JR; Okano M; Taguchi Y; Sanger WG; Beisel KW
Int J Cancer; 1991 Feb; 47(4):510-7. PubMed ID: 1847355
[TBL] [Abstract][Full Text] [Related]
12. T cells or active Epstein-Barr virus infection in the development of lymphoproliferative disease in human B cell-injected severe combined immunodeficient mice.
Coles RE; Boyle TJ; DiMaio JM; Berend KR; Via DF; Lyerly HK
Ann Surg Oncol; 1994 Sep; 1(5):405-10. PubMed ID: 7531601
[TBL] [Abstract][Full Text] [Related]
13. Lymphomagenesis in the SCID-hu mouse involves abundant production of human interleukin-10.
Baiocchi RA; Ross ME; Tan JC; Chou CC; Sullivan L; Haldar S; Monne M; Seiden MV; Narula SK; Sklar J
Blood; 1995 Feb; 85(4):1063-74. PubMed ID: 7849294
[TBL] [Abstract][Full Text] [Related]
14. Identification of IgH gene rearrangement and immunophenotype in an animal model of Epstein-Barr virus-associated lymphomas.
Zhang Y; Peng X; Tang Y; Gan X; Wang C; Xie L; Xie X; Gan R; Wu Y
J Med Virol; 2016 Oct; 88(10):1804-13. PubMed ID: 26991077
[TBL] [Abstract][Full Text] [Related]
15. Human-derived IgG level as an indicator for EBV-associated lymphoma model in Hu-PBL/SCID chimeras.
Tang Y; He R; Zhang Y; Liu F; Cheng A; Wu Y; Gan R
Virol J; 2011 May; 8():213. PubMed ID: 21554672
[TBL] [Abstract][Full Text] [Related]
16. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
Gregory CD; Rowe M; Rickinson AB
J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
[TBL] [Abstract][Full Text] [Related]
17. Construction of hu-PBL/SCID chimeras and development of EBV-related lymphomas.
Gan RL; Lan K; Yin ZH; Wang LJ; Song Y; Yao KT
Chin Med Sci J; 2005 Mar; 20(1):16-22. PubMed ID: 15844306
[TBL] [Abstract][Full Text] [Related]
18. Local growth of a Burkitt's lymphoma versus disseminated invasive growth of the autologous EBV-immortalized lymphoblastoid cells and their somatic cell hybrids in SCID mice.
Walter J; Möller P; Moldenhauer G; Schirrmacher V; Pawlita M; Wolf J
Int J Cancer; 1992 Jan; 50(2):265-73. PubMed ID: 1309726
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus nuclear protein 2 is a critical determinant for tumor growth in SCID mice and for transformation in vitro.
Cohen JI; Picchio GR; Mosier DE
J Virol; 1992 Dec; 66(12):7555-9. PubMed ID: 1331538
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus-induced human B-cell lymphomas in SCID mice reconstituted with human peripheral blood leukocytes.
Mosier DE; Picchio GR; Baird SM; Kobayashi R; Kipps TJ
Cancer Res; 1992 Oct; 52(19 Suppl):5552s-5553s. PubMed ID: 1327510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
